Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Sample Collection and Tracking for the Developmental Therapeutics Clinic
Recruiting
  • Neoplasms
  • Lymphoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    N
    Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
    Recruiting
    • Lymphoma
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    N
    Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
    Recruiting
    • Epstein-Barr Virus Infections
    • +3 more
    • Nivolumab
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    N
    Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
    Recruiting
    • Leukemia
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2022-04-07
      Apr 7, 2022
      N
      Pembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma (PCNSL), and Other Extranodal Diffuse Large B-cell Lymphomas
      Active, not recruiting
      • Non-Hodgkin Lymphoma
      • +4 more
      • Pembrolizumab
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2022-04-07
      Apr 7, 2022
      N
      Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas
      Recruiting
      • Solid Tumors
      • Lymphoma
      • Bethesda, Maryland
      • +1 more
      2022-04-07
      Apr 7, 2022
      N
      Vaccine Responses in Patients With B Cell Malignancies
      Not yet recruiting
      • Lymphoma
      • PNEUMOVAX 23
      • +9 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2022-04-07
      Apr 7, 2022
      N
      Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
      Recruiting
      • Prostate Cancer
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        2022-04-07
        Apr 7, 2022
        T
        A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma
        Recruiting
        • Lymphoma
        • No Intervention
        • Hefei, Anhui, China
        • +23 more
        2022-04-07
        Apr 7, 2022
        N
        Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma
        Recruiting
        • Lymphoma
        • +3 more
        • obinutuzumab
        • +5 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        2022-04-07
        Apr 7, 2022
        N
        A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy, Including Boost...
        Recruiting
        • Solid Tumor Malignancy
        • +4 more
        • mRNA-1273
        • Bethesda, Maryland
        • +1 more
        2022-04-07
        Apr 7, 2022
        N
        Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
        Not yet recruiting
        • Lymphoma
        • Leukemia
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          2022-04-07
          Apr 7, 2022
          N
          Safety Study of Cord Blood Units for Stem Cell Transplants
          Recruiting
          • Aplastic Anemia
          • +3 more
          • Cord Blood Units
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          2022-04-07
          Apr 7, 2022
          M
          In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies
          Recruiting
          • Acute Lymphocytic Leukemia
          • Lymphoma
          • Biological/Genetically Modified T cells
          • Cyclophosphamide-based chemotherapy
          • New York, New York
            Memorial Sloan Kettering Cancer Center
          2022-04-07
          Apr 7, 2022
          N
          Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins
          Completed
          • Lymphoma
          • Lymphoid Hyperplasia
            • Bethesda, Maryland
              National Cancer Institute (NCI), 9000 Rockville Pike
            2022-04-07
            Apr 7, 2022
            N
            A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas - 2017
            Completed
            • Neoplasms
            • Lymphoma
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            2022-04-07
            Apr 7, 2022
            N
            Agriculture Health Study
            Active, not recruiting
            • Prostate Cancer
            • +3 more
              • Iowa City, Iowa
              • +1 more
              2022-04-07
              Apr 7, 2022
              C
              CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma
              Recruiting
              • Lymphoma, Non-Hodgkin
              • +6 more
              • CB-010
              • +2 more
              • Scottsdale, Arizona
              • +5 more
              2022-04-05
              Apr 5, 2022
              N
              Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
              Recruiting
              • Advanced Malignant Solid Neoplasm
              • +49 more
              • Birmingham, Alabama
              • +1423 more
              2022-04-06
              Apr 6, 2022
              M
              Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation
              Recruiting
              • Acute Lymphoblastic Leukemia
              • +3 more
              • Allogeneic Bone Marrow Transplantation
              • +10 more
              • Houston, Texas
                M D Anderson Cancer Center
              2022-03-31
              Mar 31, 2022
              T
              A Trial of TTI-622 in Patients With Advanced Hematologic Malignancies
              Recruiting
              • Lymphoma
              • +3 more
              • Los Angeles, California
              • +13 more
              2022-03-28
              Mar 28, 2022
              D
              A Study of the Safety and Efficacy of EBV Specific T-cell Lines
              Recruiting
              • Epstein-Barr Virus Infections
              • +2 more
              • Group A
              • Group B
              • Montreal, Quebec, Canada
                Hôpital Maisonneuve-Rosemont
              2022-04-05
              Apr 5, 2022
              N
              Collection and Storage of Tissue and Blood Samples From Patients With Cancer
              Recruiting
              • Lymphoma
              • +6 more
              • Cytology Specimen Collection Procedure
              • Birmingham, Alabama
              • +139 more
              2022-04-05
              Apr 5, 2022
              F
              Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study
              Not yet recruiting
              • Clinical Stage I Cutaneous Melanoma AJCC v8
              • +33 more
              • Informational Intervention
              • +4 more
              • Los Angeles, California
              • +4 more
              2022-04-04
              Apr 4, 2022
              S
              A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia
              Recruiting
              • Leukemia
              • Lymphoma
              • Patient-derived CD19- and CD22 specific CAR
              • Los Angeles, California
              • +4 more
              2022-04-02
              Apr 2, 2022